Melbourne: The clinical trial of a vaccine being developed for the prevention of coronavirus in Australia has been discontinued in the initial phase because...
New Delhi:The Drugs Controller General of India has approved Itolizumab for restricted emergency use on COVID-19 patients with moderate to severe acute respiratory distress...